Enhancing the treatment of metabolic syndrome with integrative medicine

Journal of Chinese Integrative Medicine

Volumn 11, Issue 3, 2013, Pages 153-156

  Wang, Wen jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chinese herbal; Drugs; Insulin resistance; Metabolic syndrome X; Review

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; METFORMIN; PLANT MEDICINAL PRODUCT; ROSIGLITAZONE;

CARDIOVASCULAR DISEASE; CHINESE MEDICINE; EDITORIAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN SENSITIVITY; INTEGRATIVE MEDICINE; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MICROALBUMINURIA; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; SPLEEN FUNCTION; TREATMENT RESPONSE;

EID: 84878641578     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jintegrmed2013033     Document Type: Editorial

References (10)

1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14): 1113-1132.
2. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28(4): 629-636.
3. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3): 433-438.
4. China Food and Drug Administration. Report of adverse drug reactions 2010. (2011-04-25) [2013-03-16]. http:// www.sda.gov.cn/WS01/CL0051/60952.html. Chinese.
5. Rubins HB. Triglycerides and coronary heart disease: implications of recent clinical trials. J Cardiovasc Risk. 2000; 7(5): 339-345.
6. Wang WJ. Foundation and application of aggregation syndrome theory in traditional Chinese medicine. J Chin Integr Med. 2007; 5(2): 111-114. Chinese with abstract in English.
7. He CY, Wang WJ, Li B, Xu DS, Chen WH, Ying J, He YM. Clinical research of Yiqi Sanju Formula in treating central obese men at high risk of metabolic syndrome. J Chin Integr Med. 2007; 5(3): 263-267. Chinese with abstract in English.
8. Lou SY, Liu Y, Ma YY, Chen HY, Chen WH, Ying J, He YM, Wang WJ. Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial. J Chin Integr Med. 2008; 6(8): 793-798. Chinese with abstract in English.
9. Wang TZ, Chen Y, Chen Y, He YM, Fu XD, Yang HJ, Xue HL, Liu Y, Feng XT, Zhang T, Wang WJ. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. J Integr Med. 2013; 11(3): 175-183.
10. Chen Y, Fu DY, Chen Y, He YM, Fu XD, Xu YQ, Liu Y, Feng XT, Zhang T, Wang WJ. Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial. J Integr Med. 2013; 11(3): 184-194.